Sandbox Reserved 827: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
<Structure load='4IM3' size='400' frame='true' align='right' caption='TBK1' scene='Insert optional scene name here' />
<Structure load='4IM3' size='400' frame='true' align='right' caption='TBK1' scene='Insert optional scene name here' />


== Global structure ==
= Global structure =


=Protomer=
==Protomer==


'''Kinase domain :'''
'''Kinase domain :'''
Line 18: Line 18:
'''Coiled coil :'''
'''Coiled coil :'''


=Dimer=
==Dimer==




== Possible residue modifications ==
= Possible residue modifications =


Several residues of TBK1 can be modified, by phosphorylation or polyubiquitination.  
Several residues of TBK1 can be modified, by phosphorylation or polyubiquitination.  
Line 32: Line 32:




== Diseases ==
= Diseases =


'''Interaction with viral proteins :'''
'''Interaction with viral proteins :'''
Line 42: Line 42:
In case of some cancers, the permanent activation of TBK1 may be responsible of the proliferation of the cancerous cells. Since the substrates of TBK1 are involved in the proliferation pathway when phosphorylated, this permanent activation is a reason of the non apoptosis state of cells, and therefore of their proliferation.
In case of some cancers, the permanent activation of TBK1 may be responsible of the proliferation of the cancerous cells. Since the substrates of TBK1 are involved in the proliferation pathway when phosphorylated, this permanent activation is a reason of the non apoptosis state of cells, and therefore of their proliferation.


== References ==
= References =
Q05127
Q05127

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA, Léa Faivre